Author

Laura Torres

Novartis (Switzerland)ORCID 0009-0009-2362-0644Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 1 Synthetic Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 1

Frequent Co-Authors

Gabriel MitchelliD· 2 shared Alexander Theodore Chao· 1 shared Alexandra Hinniger· 1 shared Alexandra Lavoisier· 1 shared Alexandra ProbstiD· 1 shared Alexandro LandshammeriD· 1 shared Anke Harupa-ChungiD· 1 shared Armand Guiguemde· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersSynthetic Biology

Gabriel MitchellORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Synthetic BiologyNature CommunicationsPeer-reviewedDec 3, 2025

Development of a p62 biodegrader for autophagy targeted degradation

Zacharias Thiel, David Marcellin, Carole Manneville…·Beat Nyfeler

The paper develops a p62-based biodegrader that selectively degrades mitochondria via autophagy but not cytosolic proteins due to its effect on p62 self-oligomerization.

9 citationstop 3%

experimental assaydrug response / drug discovery

𝕏 PostBluesky

MicrobiologybioRxivPreprintOct 26, 2025

Screening of a chemogenetic library unveils dual-stage antimalarials with low cytotoxicity

Laura Torres, Matthew E. Fishbaugher, Melanie Lam…·Gabriel Mitchell

This study screens a chemogenetic library to identify antimalarial compounds with dual-stage activity against Plasmodium liver and blood stages, showing low cytotoxicity.

DOI 10.1101/2025.10.26.684713

humanexperimental assay

𝕏 PostBluesky